Estados Unidos · Revistas de economía · Inc.

Moderna’s Co-Founder Tests Up to 100 Company Ideas a Year. The Winners Aren’t His Biggest Advantage

Publicado por Inc. · Estados Unidos hace 3 h

Noubar Afeyan explains how Flagship Pioneering tests radical biotech ideas before committing millions to them.

Leer el artículo completo en Inc. Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.inc.com)

También te puede interesar

Millennials are buying homes too late to build wealth like their parents did

Canada expects to seal a deal in June to become the EU’s first ‘associate member’ — ‘everything short of full EU membership’

Nasdaq Falls Another 747 Points as Intel Is Way Outside: Stock Market Today

Could Canva’s newest AI feature end graphic design slop?

How ‘Ghosts’ Star Asher Grodman Learned to Fly by the Seat of His Pants. (Without Wearing Any Pants.)

Markets Insider (Business Insider)

AIXONA Announces AI-Powered Transaction Optimization and Expansion into European and Canadian Markets